Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ancrod (Viprinexun) (1 trial)
sodium chloride (1 trial)
Deafness (Phase 2)
Ear Diseases (Phase 2)
Hearing Disorders (Phase 2)
Hearing Loss (Phase 2)
Hearing Loss, Sensorineural (Phase 2)
Trials (1 total)
Trial APIs (2 total)